(Q47582945)

4 February 2018

title

Paradoxical HDL-C reduction during rosiglitazone and fibrate treatment. (English)

1 reference

4 February 2018

1 reference

Shetty C

1

1 reference

4 February 2018

Balasubramani M

2

1 reference

4 February 2018

Capps N

3

1 reference

4 February 2018

Milles J

4

1 reference

4 February 2018

Ramachandran S

5

1 reference

4 February 2018

publication date

1 January 2007

1 reference

4 February 2018

published in

Diabetic Medicine

1 reference

4 February 2018

volume

24

1 reference

4 February 2018

issue

1

1 reference

4 February 2018

page(s)

94-97

1 reference

4 February 2018

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02029.X

Paradoxical lowering of high-density lipoprotein cholesterol level in 2 patients receiving fenofibrate and a thiazolidinedione

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02029.X

Mechanism of action of fibrates on lipid and lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02029.X

Comparison of effects of thiazolidinediones on cardiovascular risk factors: observations from a clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02029.X

Metabolism of Apolipoproteins AI and AII in a Patient with Paradoxical Reduction in High-Density Lipoprotein Due to Ciprofibrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02029.X

10.1111/J.1464-5491.2007.02029.X

21 January 2018

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

17227331

1 reference

4 February 2018